Medtronic posted a strong profit for Q3 of fiscal year 2025, though shares were down as its cardiac ablation product success was offset by weaker sales from its medical-surgical business. The medtech ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback